CFDA Unveils New Details Of Drug Safety Plan To Give Provinces More Power
This article was originally published in PharmAsia News
Executive Summary
In his first major speech since SFDA’s reorganization, newly appointed China FDA Deputy Commissioner Yin Li laid out the agency’s plans to delegate drug safety oversight to provincial regulators but place responsibility on manufacturers.